Profound Medical Valuation

PROF Stock  USD 7.50  0.02  0.27%   
At this time, the company appears to be fairly valued. Profound Medical Corp holds a recent Real Value of $7.38 per share. The prevailing price of the company is $7.5. Our model determines the value of Profound Medical Corp from analyzing the company fundamentals such as Operating Margin of (1.69) %, shares outstanding of 36.29 M, and Return On Equity of -1.24 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Profound Medical's valuation include:
Price Book
8.4457
Enterprise Value
244.8 M
Enterprise Value Ebitda
(5.75)
Price Sales
19.0388
Enterprise Value Revenue
17.1214
Fairly Valued
Today
7.50
Please note that Profound Medical's price fluctuation is slightly risky at this time. Calculation of the real value of Profound Medical Corp is based on 3 months time horizon. Increasing Profound Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Profound stock is determined by what a typical buyer is willing to pay for full or partial control of Profound Medical Corp. Since Profound Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Profound Stock. However, Profound Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  7.5 Real  7.38 Target  12.35 Hype  7.5 Naive  7.27
The real value of Profound Stock, also known as its intrinsic value, is the underlying worth of Profound Medical Corp Company, which is reflected in its stock price. It is based on Profound Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Profound Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
7.38
Real Value
11.07
Upside
Estimating the potential upside or downside of Profound Medical Corp helps investors to forecast how Profound stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Profound Medical more accurately as focusing exclusively on Profound Medical's fundamentals will not take into account other important factors:
Earnings
Estimates
LowProjectedHigh
-0.33-0.25-0.18
Details
Hype
Prediction
LowEstimatedHigh
3.817.5011.19
Details
Naive
Forecast
LowNext ValueHigh
3.587.2710.96
Details
5 Analysts
Consensus
LowTarget PriceHigh
11.2412.3513.71
Details
When choosing an evaluation method for Profound Medical Corp, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.

Profound Medical Cash

34.92 Million

Profound Revenue by Product

Profound Medical Total Value Analysis

Profound Medical Corp is at this time estimated to have valuation of 244.78 M with market capitalization of 272.2 M, debt of 5.12 M, and cash on hands of 46.21 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Profound Medical fundamentals before making equity appraisal based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
244.78 M
272.2 M
5.12 M
46.21 M

Profound Medical Investor Information

About 34.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 1.32. Profound Medical Corp last dividend was issued on the 16th of October 2019. The entity had 1:10 split on the 16th of October 2019. Profound Medical Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.

Profound Medical Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Profound Medical has an asset utilization ratio of 14.48 percent. This implies that the Company is making $0.14 for each dollar of assets. An increasing asset utilization means that Profound Medical Corp is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid
 
Interest Hikes

Profound Medical Profitability Analysis

Taking into consideration Profound Medical's profitability measurements, Profound Medical Corp may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Profound Medical's ability to earn profits and add value for shareholders.
 
Net Loss  
First Reported
2014-03-31
Previous Quarter
-15.7 M
Current Value
-7.9 M
Quarterly Volatility
3.7 M
 
Yuan Drop
 
Covid
 
Interest Hikes
The Profound Medical's current Gross Profit is estimated to increase to about 8.1 M, while Pretax Profit Margin is projected to decrease to (2.46).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.390.59
Way Down
Slightly volatile
For Profound Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Profound Medical Corp to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Profound Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Profound Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Profound Medical over time as well as its relative position and ranking within its peers.

Profound Medical Earnings per Share Projection vs Actual

By analyzing Profound Medical's earnings estimates, investors can diagnose different trends across Profound Medical's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Profound Medical Corp is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Yuan Drop
 
Covid
 
Interest Hikes
Profound Medical is projected to generate -0.252 in earnings per share on the 31st of December 2026. Profound Medical earnings estimates show analyst consensus about projected Profound Medical EPS (Earning Per Share). It derives the highest and the lowest estimates based on Profound Medical's historical volatility. Many public companies, such as Profound Medical, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

Profound Medical Ownership Allocation

Profound Medical owns a total of 36.29 Million outstanding shares. 30% of Profound Medical Corp outstanding shares are owned by third-party entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.

Profound Medical Profitability Analysis

The company reported the previous year's revenue of 10.17 M. Net Loss for the year was (27.82 M) with profit before overhead, payroll, taxes, and interest of 10.36 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Profound Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Profound Medical and how it compares across the competition.

About Profound Medical Valuation

The stock valuation mechanism determines Profound Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Profound Medical. We calculate exposure to Profound Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Profound Medical's related companies.
Last ReportedProjected for Next Year
Gross Profit7.7 M8.1 M
Pretax Profit Margin(2.34)(2.46)
Operating Profit Margin(2.79)(2.93)
Net Loss(2.34)(2.46)
Gross Profit Margin 0.59  0.39 

Profound Medical Current Valuation Indicators

Valuation refers to the process of determining the present value of Profound Medical Corp and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Profound we look at many different elements of the entity such as Profound's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Profound Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Profound Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Profound Medical's worth.

Complementary Tools for Profound Stock analysis

When running Profound Medical's price analysis, check to measure Profound Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Profound Medical is operating at the current time. Most of Profound Medical's value examination focuses on studying past and present price action to predict the probability of Profound Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Profound Medical's price. Additionally, you may evaluate how the addition of Profound Medical to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Commodity Directory
Find actively traded commodities issued by global exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios